Bifeprunox derivatives

Details for Australian Patent Application No. 2009204851 (hide)

Owner Abbott Healthcare Products B.V.

Inventors Van Stuivenberg, Herman H.; Barf, Gerrit A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009204851

PCT Pub. Number WO2009/090177

Priority 61/021,090 15.01.08 US; 08150282.5 15.01.08 EP

Filing date 14 January 2009

Wipo publication date 23 July 2009

International Classifications

C07D 263/58 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/090177 Priority application(s): WO2009/090177

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009204852-Novel formulation

2009204849-Vaccine comprising a ribosomal protein extract (RPE) and optionally a Th1-promoting adjuvant